Parkview Health brings diabetic retinopathy tests closer to the patients

Parkview Health has deployed point-of-care retinopathy testing technology for diabetic patients to diagnose damage to their retinas. Parkview staff trained to perform the 7-minute examination in-house at several clinics. The tech has achieved patient satisfaction and reach at underperforming centres, and the FDA-approved scan is a “low-cost, high-efficacy solution”. The test provides an immediate diagnosis and minimizes obstacles such as cost and travel for patients.